
“I think it’s really important that people keep signing up to these type of trials to push research forward.”
This study is comparing FOLFOX-A chemotherapy with AG chemotherapy for pancreatic cancer that has spread elsewhere in the body. It is for people who haven’t had treatment for pancreatic cancer that has spread.
The Primus 001 study is part of a large research programme looking at new treatments for cancer of the pancreas. To take part in Primus 001, you must have already joined a study called Precision Panc. In this study, your doctor looked at the make up of your cancer and they have now matched you to have the treatment in this trial.
Cancer Research UK supports this trial.
Medical conditions
You:
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Janet Graham
Cancer Research UK
NHS Greater Glasgow and Clyde
Celgene
Freephone 0808 800 4040
“I think it’s really important that people keep signing up to these type of trials to push research forward.”